50% of consumers would change physicians for a better online healthcare experience

A report presented March 5 at HIMSS found 59 percent of American consumers want a healthcare digital customer experience to be more like online retailers.

The report, conducted by NTT DATA Services, included the responses of 1,102 U.S. consumers who stated they want digital customer experience transactions, such as fulling prescriptions and accessing test results, to mimic retail giants like Amazon and Apple.

“Consumer-focused brands with rich, engaging content, interactions and features have changed the landscape in digital customer experience, and healthcare is lagging behind,” said Alan Hughes of NTT DATA Services. “As patients seek seamless care to bring together services related to diagnosis, treatment, rehabilitation and health promotion, healthcare appears ripe for its own digital transformation.”

Key findings included:

  • 78 percent of more “tech-savvy” consumers said the digital customer experience in healthcare needed improvement.
  • 50 percent of more “tech-savvy” consumers would leave their current physician for a better digital customer experience.
  • 62 percent of respondents stated not being able to accomplish what they wanted to do as the main factor hindering mobile care, followed by non-relevant options at 42 percent.
  • 69 percent of respondents expected an insurance company to make navigating affordable care and wellness options easier.
  • 81 percent of consumers stated searching for a physician/specialist as the top area for improvement, followed by accessing family health records (80 percent), making appointments (79 percent), accessing test results (76 percent), paying bills (75 percent) and filling prescriptions (74 percent).

“Patient preferences and age demographics will continue to increase the emphasis healthcare organizations place on digital customer experience,” Hughes said. “While digital experience may have a moderate impact on overall healthcare decisions made today, it is changing at an increasing rate. Providers, insurers and pharmacies taking heed of the trend will be best suited to fulfill patient expectations."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.